Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Dirigidas en Enfermedades Reumáticas

Biobadaser Fase III

Evolution of Janus Kinase inhibitors (JAKi) prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study): effect of regulatory warnings

18/06/2026

Mongin D et al (JAK-POT)

Semin Arthritis Rheum

https://doi.org/10.1016/j.semarthrit.2026.152946

doi: 10.1016/j.semarthrit.2026.152946